{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:59:28Z","timestamp":1793325568576,"version":"4.5.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,7,21]]},"abstract":"\n Importance<\/jats:title>\n Excess body weight is a strong risk factor for atrial fibrillation (AF), and weight loss is recommended in clinical guidelines for all patients with obesity and AF. However, existing evidence derives from younger patients, and weight loss in older adults could precipitate frailty.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate whether weight loss is a safe and effective intervention in older patients with overweight and AF.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Parallel-group, unblinded, randomized clinical trial conducted at 2 UK hospitals from November 14, 2018, to April 25, 2025. Approximately 1500 individuals undergoing electrical cardioversion for AF were assessed for eligibility, and approximately 500 aged 60 to 85 years with body mass index 27 or greater and without any exclusion criteria were invited to participate. Of these, 119 provided informed consent to enter the trial and 118 were randomized.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Participants were randomized to an 8-month low-calorie diet and behavioral support program (intervention, n\u2009=\u200959) or to usual care (control, n\u2009=\u200959).<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measure<\/jats:title>\n Intention-to-treat analysis of the change in Atrial Fibrillation Severity Scale (AFSS) symptom severity score at 8 months after randomization.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Participants (n\u2009=\u2009118) had a mean age of 68 years (SD, 6); 33% were female. The intervention resulted in significantly lower weight (baseline-adjusted mean weight at 8 months: 92.6 [SE, 0.85] kg vs 99.4 [SE, 0.85] kg;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; estimated difference, \u22126.9 kg [95% CI, \u22129.2 to \u22124.5]). This corresponded to a weight reduction of 9.7% vs 3.1%, respectively (\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). However, there were no significant differences between the groups in AFSS symptom severity score (baseline-adjusted mean at 8 months, 7.9 [SE, 0.84] in the intervention group vs 8.9 [SE, 0.84] in the control group; between-group difference, \u22120.9 [95% CI, \u22123.3 to 1.4];\n P<\/jats:italic>\n \u2009=\u2009.43). No significant treatment effects were observed on physical performance, AF burden, cardiac imaging parameters, blood pressure, lipid profile, or incidence of repeat cardioversion or AF ablation during follow-up. No serious adverse events related to participation in the trial were reported in either group.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In older patients with overweight and persistent AF, a low-calorie diet and behavioral support program was associated with significant weight loss at 8 months with no safety concerns but did not affect AF symptoms, AF burden, cardiac remodeling, or the need for further rhythm control interventions.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT03713775<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2026.5787","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:30:36Z","timestamp":1779291036000},"page":"205","source":"Crossref","is-referenced-by-count":10,"title":["Weight Loss in Older Patients With Persistent Atrial Fibrillation"],"prefix":"10.1001","volume":"336","author":[{"given":"Matteo","family":"Sclafani","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"},{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spartera","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Esmati","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Baynham-Williams","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianna","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Brigoli","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Krasopoulos","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Ormerod","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pok-Tin","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Rider","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Valkovi\u010d","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"},{"name":"Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Emberson","sequence":"additional","affiliation":[{"name":"Clinical Trial Service and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Casadei","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Wijesurendra","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"},{"name":"Clinical Trial Service and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"joi260032r1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021.","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"issue":"35","key":"joi260032r2","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"issue":"11","key":"joi260032r3","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States.","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"11","key":"joi260032r4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study.","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"11","key":"joi260032r5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/europace\/eux288","article-title":"Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias: the results of the European Heart Rhythm Association survey.","volume":"19","author":"Fumagalli","year":"2017","journal-title":"Europace"},{"issue":"2","key":"joi260032r6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF03324785","article-title":"Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA study.","volume":"22","author":"Fumagalli","year":"2010","journal-title":"Aging Clin Exp Res"},{"issue":"8","key":"joi260032r7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.110.947978","article-title":"Birth weight is a significant risk factor for incident atrial fibrillation.","volume":"122","author":"Conen","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"joi260032r8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/eurheartj\/ehp076","article-title":"Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.","volume":"30","author":"Rosengren","year":"2009","journal-title":"Eur Heart J"},{"issue":"21","key":"joi260032r9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women\u2019s Health Study).","volume":"55","author":"Tedrow","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"joi260032r10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity\u2014results of a meta-analysis.","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"issue":"20","key":"joi260032r11","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation.","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"issue":"36","key":"joi260032r12","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"joi260032r13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"10120","key":"joi260032r14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care\u2013led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"joi260032r15","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY).","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"joi260032r16","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"joi260032r17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial.","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"issue":"1","key":"joi260032r18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacc.2025.04.042","article-title":"Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial.","volume":"86","author":"Osmancik","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"joi260032r19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"joi260032r20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/BF02982710","article-title":"The danger of weight loss in the elderly.","volume":"12","author":"Miller","year":"2008","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"joi260032r21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.mco.0000165002.08955.5b","article-title":"Pathophysiology of peripheral muscle wasting in cardiac cachexia.","volume":"8","author":"Filippatos","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"10","key":"joi260032r22","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.biocel.2005.03.013","article-title":"Muscle wasting in cardiac cachexia.","volume":"37","author":"Strassburg","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"joi260032r23","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"joi260032r24","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"issue":"9310","key":"joi260032r25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(02)08029-7","article-title":"Unequal group sizes in randomised trials: guarding against guessing.","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"joi260032r26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1532-5415.1990.tb01373.x","article-title":"An objective measure of physical function of elderly outpatients: the Physical Performance Test.","volume":"38","author":"Reuben","year":"1990","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"joi260032r27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults.","volume":"364","author":"Villareal","year":"2011","journal-title":"N Engl J Med"},{"issue":"20","key":"joi260032r28","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/NEJMoa1616338","article-title":"Aerobic or resistance exercise, or both, in dieting obese older adults.","volume":"376","author":"Villareal","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"joi260032r29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial.","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"22","key":"joi260032r30","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/CIRCULATIONAHA.115.017007","article-title":"Simultaneous biatrial high-density (510-512 electrodes) epicardial mapping of persistent and long-standing persistent atrial fibrillation in patients: new insights into the mechanism of its maintenance.","volume":"132","author":"Lee","year":"2015","journal-title":"Circulation"},{"key":"joi260032r31","doi-asserted-by":"publisher","first-page":"ii22","DOI":"10.1093\/europace\/euab257","article-title":"Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes.","volume":"24","author":"Gunawardene","year":"2022","journal-title":"Europace"},{"issue":"21","key":"joi260032r32","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"24","key":"joi260032r33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes.","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"joi260032r34","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1111\/jce.16090","article-title":"The effect of weight loss on recurrence of atrial fibrillation after catheter ablation: a systematic review and meta-analysis.","volume":"34","author":"Akhtar","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"joi260032r35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"joi260032r36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes.","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2849335\/jama_sclafani_2026_oi_260032_1783976440.75516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:43Z","timestamp":1784646043000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2849335"}},"subtitle":["The LOSE-AF Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.5787","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}